Figure 1

Kaplan-Meier curves for overall survival probability according to (A) CRP, (B) NLR and (C) a combination of CRP and NLR. (A) Patients with CRP > 6.3 mg/L (dotted line) had a significantly shorter overall survival than those with CRP ≤ 6.3 mg/L (solid line) (median 6.0 vs. 26.9 months, respectively; p < 0.001). (B) Likewise, survival among patients with NLR > 2.3 (dotted line) was shorter than those with NLR ≤ 2.3 (solid line) (median 7.9 vs. 32.5 months, respectively; p < 0.001). (C) There is a significantly longer survival in the group with both CRP ≤ 6.3 mg/L and NLR ≤ 2.3 (solid line, 39.2 months) than the group with either CRP > 6.3 mg/L or NLR > 2.3 (dashed line, 14.6 months) or than the group with both CRP > 6.3 mg/L and NLR > 2.3 (dotted line, 4.6 months).